News - Page 219 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectrometer

Post published:January 13, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Invited to Present at Global Healthcare & Psychedelic Conferences

Tryp Therapeutics Invited to Present at Global Healthcare & Psychedelic Conferences

Post published:January 13, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Engages Star Finance GmbH for Investor Relations

Entheon Biomedical Engages Star Finance GmbH for Investor Relations

Post published:January 12, 2021
Post category:Press Release

Read more about the article PharmaDrug Announces LOI to Acquire Sairiyo Therapeutics Inc.

PharmaDrug Announces LOI to Acquire Sairiyo Therapeutics Inc.

Post published:January 12, 2021
Post category:Press Release

Read more about the article MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers

MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers

Post published:January 12, 2021
Post category:Press Release

Read more about the article NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity

NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity

Post published:January 12, 2021
Post category:Press Release

Read more about the article BetterLife Provides Shareholder Update and 2021 Product Development Roadmap

BetterLife Provides Shareholder Update and 2021 Product Development Roadmap

Post published:January 12, 2021
Post category:Press Release

Read more about the article Mind Cure Signs LOI to Acquire an Ownership Interest in Psychedelic Treatment Center ATMA, Selected by Section 56 Exempt Patient for Psilocybin Therapy

Mind Cure Signs LOI to Acquire an Ownership Interest in Psychedelic Treatment Center ATMA, Selected by Section 56 Exempt Patient for Psilocybin Therapy

Post published:January 12, 2021
Post category:Press Release

Read more about the article Cybin Announces API Synthesis of Multiple Tryptamine Derivatives Based on the First Milestone Achievement Pursuant to the Adelia Acquisition

Cybin Announces API Synthesis of Multiple Tryptamine Derivatives Based on the First Milestone Achievement Pursuant to the Adelia Acquisition

Post published:January 11, 2021
Post category:Press Release

Read more about the article Ehave Forms Partnership with Cognitive Apps to Introduce Revolutionary AI Voice Assistant That Will Revolutionize Mental Health in Psychedelic Sector

Ehave Forms Partnership with Cognitive Apps to Introduce Revolutionary AI Voice Assistant That Will Revolutionize Mental Health in Psychedelic Sector

Post published:January 11, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.